TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

51.00$ -1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 330 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANAB
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
517 487 452 406 427 493 484 422 335 353 364 330
439 428 407 372 367 449 432 363 292 331 350 316
35 26 36 54 72 192 123 99 44 110 238 248
429 413 391 355 351 430 385 340 266 249 312 286
3.2 3.3 6.9 7.1 9.0 12 41 18 21 76 34 26
– 0.0 0.0 0.0 0.0 -12 – – – – – –
2.0 19 – – – – – – – – – –
369 367 364 358 417 409 413 388 380 383 327 317
42 39 37 32 40 44 45 44 36 38 39 42
1.7 1.7 1.8 1.8 1.9 1.9 1.9 2.0 2.0 2.0 2.1 2.1
4.8 6.5 4.7 4.6 4.9 3.6 4.0 6.1 3.3 2.9 3.9 7.5
148 120 88 48 9.9 84 71 34 -45 -29 37 13
-535 -572 -614 -658 -705 -738 -759 -799 -837 -822 -773 -825
27 27 27 27 27 29 30 31 29 29 31 29

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?